It costs an estimated $2.6B to bring a single molecule to market, of which 90 percent fail clinical studies. And we don’t know why. During this briefing, WIRED’s deputy global editorial director, Greg Williams spoke with Professor Yaakov Nahmias, founder of Tissue Dynamics, regarding the future of drug development and how it is dramatically increasing clinical success rates by using sensor-driven discovery.